Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
129.14
-1.22 (-0.94%)
At close: Oct 27, 2025, 4:00 PM EDT
129.40
+0.26 (0.20%)
After-hours: Oct 27, 2025, 7:58 PM EDT
Novartis AG Revenue
Novartis AG had revenue of $14.84B in the quarter ending June 30, 2025, with 15.26% growth. This brings the company's revenue in the last twelve months to $55.19B, up 12.95% year-over-year. In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth.
Revenue (ttm)
$55.19B
Revenue Growth
+12.95%
P/S Ratio
4.55
Revenue / Employee
$727,251
Employees
75,883
Market Cap
250.89B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.72B | 5.06B | 10.85% |
| Dec 31, 2023 | 46.66B | 3.20B | 7.36% |
| Dec 31, 2022 | 43.46B | -513.00M | -1.17% |
| Dec 31, 2021 | 43.97B | -5.92B | -11.87% |
| Dec 31, 2020 | 49.90B | 1.22B | 2.51% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
| Abbott Laboratories | 43.84B |
NVS News
- 8 hours ago - Avidity Biosciences Soars After $72 Per Share Novartis Takeover - Benzinga
- 9 hours ago - Novartis AG (NVS) M&A Call Transcript - Seeking Alpha
- 14 hours ago - 5 Things to Know Before the Stock Market Opens - Investopedia
- 15 hours ago - Trump's trade deals, Novartis acquires Avidity, Taco Bell's beverage push and more in Morning Squawk - CNBC
- 16 hours ago - Wall Street Breakfast Podcast: Novartis Puts $12B On The Table - Seeking Alpha
- 17 hours ago - Novartis shares slip, Avidity soars after $12 billion biotech deal - Reuters
- 1 day ago - Novartis Agrees to Acquire Avidity Biosciences for $12 Billion - WSJ
- 1 day ago - Novartis to acquire Avidity Biosciences for about $12B - New York Post